Zobrazeno 1 - 10
of 77
pro vyhledávání: '"RONALD L. STEPHENS"'
Autor:
Donald P. Quick, T. J. O'Rourke, James R. Faulkner, Mark J. Noble, Geoffrey R. Weiss, Stephen R. Smalley, Ronald L. Stephens, Ian M. Thompson, E. David Crawford, Gregory P. Swanson
Publikováno v:
Journal of Urology. 176:548-553
Radiation is considered the standard treatment for locally advanced (T3 and T4) prostate cancer but cure with radiation alone is infrequent. Studies have shown that adding androgen ablation improves the results but there is still much room for improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0720a75c9de31e81d3b95429c85b12f
https://doi.org/10.1016/j.juro.2006.03.068
https://doi.org/10.1016/j.juro.2006.03.068
Autor:
William S. Fletcher, Ronald L. Stephens, Lawrence E. Flaherty, P. Y. Liu, Michael Walker, Malcolm S. Mitchell, Vernon K. Sondak, John Wendall Goodwin
Publikováno v:
American Journal of Clinical Oncology. 19:108-113
Based on the reports of substantial improvement in the response rate w ith the addition of tamoxifen to a multiagent chemotherapy regimen for metastatic melanoma, Southwest Oncology Group (SWOG)-8921 was initiated. A prior regimen (SWOG-8804) of daca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2352367002988ab072671b9e010f9f78
https://doi.org/10.1097/00000421-199604000-00004
https://doi.org/10.1097/00000421-199604000-00004
Autor:
Mark J. Noble, Raj Sadasivan, R. Morgan, Ronald L. Stephens, Mark S. Austenfeld, Scott Jennings, P J Van Veldhuizen
Publikováno v:
Journal of Urology. 150:126-131
Previous reports have shown that Her-2/neu oncogene expression in human breast cancer and ovarian cancer may be associated with poorer prognosis. We report the expression of Her-2/neu on fresh samples of known prostatic adenocarcinoma but not on thos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324f13691889911298b5e3b6dd6af47d
https://doi.org/10.1016/s0022-5347(17)35413-7
https://doi.org/10.1016/s0022-5347(17)35413-7
Publikováno v:
The American Journal of the Medical Sciences. 305:275-279
Incidental prostate cancer is an indolent disease typically characterized by a benign clinical course. This is not clearly established, however, as recent reports suggest that up to 27% of cases progress with long-term follow-up. The indolent history
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3545c23aac239ea6e40fcb2276a08a25
https://doi.org/10.1097/00000441-199305000-00001
https://doi.org/10.1097/00000441-199305000-00001
Publikováno v:
The Prostate. 22:23-30
The expression of the mutant p53 tumor suppressor gene was evaluated in 33 human prostate carcinomas. Using an immunohistochemical method with monoclonal antibodies PAb 1801 and PAb 240, 26 (79%) tumors demonstrated positive immunostaining for mutant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c50153c885a872c861edd8d8a54719a
https://doi.org/10.1002/pros.2990220104
https://doi.org/10.1002/pros.2990220104
Autor:
M Wolfe, D E Crawford, Ronald L. Stephens, Ronald M. Bukowski, W G Harker, Ellen R. Gaynor, H S Levine
Publikováno v:
Journal of Clinical Oncology. 11:161-165
PURPOSE Previous reports of chemotherapy in patients with adrenal cancer have described responses to cisplatin (CDDP). Because of these reports of good results, a phase II trial that used CDDP with and without mitotane (o,p'DDD) was initiated. PATIEN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::604f18efa38361d0916d12e31c9a2835
https://doi.org/10.1200/jco.1993.11.1.161
https://doi.org/10.1200/jco.1993.11.1.161
Autor:
Phyllis J. Goodman, Lawrence M. Pass, E. David Crawford, Debra W. Christie, Kutub Khan, Ronald L. Stephens, Anthony Y. Smith, William L. Nabors
Publikováno v:
Urology. 39:457-460
Beginning in 1981, 28 patients with advanced seminoma were treated with combination chemotherapy followed by irradiation to evaluate the possibility of improved survival using both modalities. The treatment protocol consisted of two courses of vincri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95c756a7697dd3933a3de3b835aeb83c
https://doi.org/10.1016/0090-4295(92)90247-t
https://doi.org/10.1016/0090-4295(92)90247-t
Publikováno v:
OMEGA - Journal of Death and Dying. 23:181-189
A pilot survey of sixty-four patients with late stage malignancy, all of whom had signed a living will, was conducted. The purpose of the living will was to have resuscitative measures withheld when cardiorespiratory arrest occurred. Of those patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0683ebdf1538c740a5d758857459dcd7
https://doi.org/10.2190/4nh3-fry4-2nhc-r44k
https://doi.org/10.2190/4nh3-fry4-2nhc-r44k
Autor:
McClure S, Gumbart C, Vaughan Cb, Charles A. Coltman, James A. Neidhart, C K Osborne, Laura F. Hutchins, Silvana Martino, Cowan Jd, Ronald L. Stephens
Publikováno v:
JNCI Journal of the National Cancer Institute. 83:1077-1084
Four hundred eleven women with metastatic breast cancer were randomly assigned to receive either 60 mg/m2 doxorubicin (130 patients), 320 mg/m2 bisantrene (146 patients), or 14 mg/m2 mitoxantrone (135 patients). The doses were given intravenously eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930da7f6c6ffcfe8d5e15616f6346852
https://doi.org/10.1093/jnci/83.15.1077
https://doi.org/10.1093/jnci/83.15.1077
Autor:
H. E. Hynes, Sarah A. Taylor, T W Pollock, Harmon J. Eyre, C Jaeckle, John Crowley, Ronald L. Stephens
Publikováno v:
Journal of Clinical Oncology. 9:1476-1479
Acivicin (AT-125) is a glutamine antagonist with dose-limiting, schedule-dependent CNS toxicity and predictable CSF penetration after intravenous administration. Because of these properties, a trial in CNS malignancies was initiated. Thirty-two patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac0c4a3f7c1e944110e3277d939e8ad
https://doi.org/10.1200/jco.1991.9.8.1476
https://doi.org/10.1200/jco.1991.9.8.1476